Swiss stocks stayed weak right through the day\'s session Monday with investors staying largely cautious amid a lack of triggers. The benchmark SMI ended down by 14.94 points or 0.13% at 11,637.05, after moving in a very tight range between 11,583.39 and 11,640.86. Swiss Life Holding, ABB and Sonova ended lower by 2.56%, 2.34% and...
The Canadian market failed to hold early gains and ended lower on Monday, pulled down by losses in healthcare, industrials, utilities and consumer discretionary stocks. A firm display by energy stocks helped limit market\'s downside. The overall mood remains a bit cautious with investors awaiting a slew of crucial U.S. and Canadian economic data. The...
The U.S. dollar shed ground against its major counterparts on Monday ahead of a slew of key economic data, including a reading on the PCE price index, which is the Fed\'s preferred measure of inflation. The core PCE price index is expected to have climbed 0.3% month-on-month in February, keeping annual reading unchanged at 2.8%....
The China stock market has finished lower in two of three trading days since the end of the two-day winning streak in which it had collected almost 50 points or 1.6 percent. The Shanghai Composite Index now rests just above the 3,075-point plateau although it figures to bounce higher again on Friday. The global forecast...
The Hong Kong stock market has finished higher in two straight sessions, advancing more than 330 points or 2 percent in that span. The Hang Seng Index now sits just above the 16,860-point plateau and it\'s expected to open in the green again on Friday. The global forecast for the Asian markets is positive on...
The Indonesia stock market has moved higher in two of three trading days since the end of the two-day slide in which it had slipped more than 30 points or 0.4 percent. The Jakarta Composite Index now sits just beneath the 7,340-point plateau and it may extend its gains on Friday. The global forecast for...
The U.S. Food and Drug Administration approved Italfarmaco S.p.A\'s Duvyzat (givinostat) oral medication for the treatment of Duchenne Muscular Dystrophy or DMD in patients six years of age and older. Duvyzat is the first nonsteroidal drug approved by the agency to treat patients with all genetic variants of DMD. It is a histone deacetylase or...
The British pound weakened against other major currencies in the European session on Friday, as traders bet on increasing expectation that the Bank of England is likely to opt for interest rate cuts later this year. The Bank of England left its benchmark interest rate unchanged at a sixteen-year high for the fifth straight session...
Equity markets in Asia finished trading on a mixed note amidst an uptick in inflation in Japan as well as uncertainties about rate cuts by the Fed. The Dollar\'s rebound as well as mixed corporate earnings weighed on sentiment. China\'s Shanghai Composite Index slipped 0.95 percent to finish trading at 3,048.03. The day\'s trading ranged...
After an early setback due to a sell-off in the technology sector following Accenture\'s weak revenue guidance, Indian shares recovered and stayed fairly steady on Friday to eventually end the day\'s session modestly higher. Optimism about interest rate cuts by central banks continued to help underpin sentiment. The BSE benchmark Sensex, which fell nearly 470...